0000899243-21-009199.txt : 20210302
0000899243-21-009199.hdr.sgml : 20210302
20210302210208
ACCESSION NUMBER: 0000899243-21-009199
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210226
FILED AS OF DATE: 20210302
DATE AS OF CHANGE: 20210302
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Cassidy Sean A
CENTRAL INDEX KEY: 0001421914
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38672
FILM NUMBER: 21706828
MAIL ADDRESS:
STREET 1: 322 EAST MAIN STREET
CITY: BRANFORD
STATE: CT
ZIP: 06405
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ARVINAS, INC.
CENTRAL INDEX KEY: 0001655759
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 472566120
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 395 WINCHESTER AVE
STREET 2: 5 SCIENCE PARK
CITY: NEW HAVEN
STATE: CT
ZIP: 06511
BUSINESS PHONE: 203-535-1456
MAIL ADDRESS:
STREET 1: 395 WINCHESTER AVE
STREET 2: 5 SCIENCE PARK
CITY: NEW HAVEN
STATE: CT
ZIP: 06511
FORMER COMPANY:
FORMER CONFORMED NAME: ARVINAS INC.
DATE OF NAME CHANGE: 20181001
FORMER COMPANY:
FORMER CONFORMED NAME: ARVINAS HOLDING COMPANY, LLC
DATE OF NAME CHANGE: 20151015
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-02-26
0
0001655759
ARVINAS, INC.
ARVN
0001421914
Cassidy Sean A
C/O ARVINAS, INC.
5 SCIENCE PARK, 395 WINCHESTER AVE.
NEW HAVEN
CT
06511
0
1
0
0
Chief Financial Officer
Common Stock
2021-03-02
4
M
0
4792
A
160470
D
Common Stock
2021-03-02
4
S
0
2221
77.4495
D
158249
D
Stock Option (right to buy)
78.30
2021-02-26
4
A
0
68000
0.00
A
2031-02-25
Common Stock
68000
0
D
Restricted Stock Units
2021-03-02
4
M
0
4792
0.00
D
Common Stock
4792
9582
D
Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock.
This sale was made to cover withholding taxes following the vesting of previously granted Restricted Stock Units.
The broker sold shares of the Issuer's common stock for certain employees following the vesting of previously granted Restricted Stock Units, including the common stock reported on this Form 4 by the reporting person, at an average price of $77.4495.
This option award was granted on February 26, 2021. 1/4 of the shares underlying the award shall vest on February 26, 2022, with the remainder of the shares vesting in equal monthly installments following February 26, 2022 through February 26, 2025.
On March 1, 2019, the reporting person was granted 19,165 Restricted Stock Units, vesting in four equal annual installments beginning March 1, 2020.
/s/ Matthew Batters, as attorney-in-fact for Sean Cassidy
2021-03-02